This study is looking at children and teenagers who need to have a colonoscopy, which is a procedure where a doctor uses a special camera to look inside the large intestine. Before this procedure can be done, the bowel needs to be completely cleaned out so the doctor can see clearly. The study will test a bowel cleansing medicine called PLENVU, which contains ascorbic acid, sodium ascorbate, potassium chloride, sodium chloride, and macrogol 3350, and compare it to another bowel cleansing medicine called sodium picosulfate. Both medicines are mixed with water to make a drink that helps empty the bowel. The study will include children and teenagers from 1 year old up to 18 years old who weigh at least 10 kilograms and need to have a colonoscopy for any reason related to colonic disease, which means any condition affecting the large intestine.
The main goal of the study is to see how well each medicine cleans the bowel by measuring the cleanliness using a scoring system called the Boston Bowel Preparation Scale. The study will also look at how well children can follow the instructions for taking the medicine, how easy it is to drink, how it tastes, and whether children experience any unwanted effects from the medicine. Participants will be randomly assigned to receive either PLENVU or sodium picosulfate, meaning it will be decided by chance which medicine they get, similar to flipping a coin. The doctor performing the colonoscopy will not know which medicine the child received, which helps make the comparison fair.
During the study, children will take the bowel cleansing medicine at home before coming to the hospital or clinic for their colonoscopy. They or their parents will keep track of how much of the medicine they were able to drink and answer questions about how they felt while taking it. The colonoscopy will be performed as planned, and the doctor will score how clean the bowel is. After the colonoscopy, there will be a follow-up period to check on the child’s safety and well-being. The study is expected to start enrolling participants in early 2026 and finish in early 2027.



Belgium
Germany
Hungary
Italy
Poland
Portugal
Spain
The Netherlands